Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP101069.RAwyo1l2NVhzHuA0IX8-ZSInYEbOaFM1XIgP1UOZYerc0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP101069.RAwyo1l2NVhzHuA0IX8-ZSInYEbOaFM1XIgP1UOZYerc0130_assertion type Assertion NP101069.RAwyo1l2NVhzHuA0IX8-ZSInYEbOaFM1XIgP1UOZYerc0130_head.
- NP101069.RAwyo1l2NVhzHuA0IX8-ZSInYEbOaFM1XIgP1UOZYerc0130_assertion description "[results of a small sample of invasive ductal breast carcinoma patients suggest that low securin expression identifies a distinct subgroup of more favourable outcome among patients with high Ki-67 immunoexpression or high mitotic activity index ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP101069.RAwyo1l2NVhzHuA0IX8-ZSInYEbOaFM1XIgP1UOZYerc0130_provenance.
- NP101069.RAwyo1l2NVhzHuA0IX8-ZSInYEbOaFM1XIgP1UOZYerc0130_assertion evidence source_evidence_literature NP101069.RAwyo1l2NVhzHuA0IX8-ZSInYEbOaFM1XIgP1UOZYerc0130_provenance.
- NP101069.RAwyo1l2NVhzHuA0IX8-ZSInYEbOaFM1XIgP1UOZYerc0130_assertion SIO_000772 18594525 NP101069.RAwyo1l2NVhzHuA0IX8-ZSInYEbOaFM1XIgP1UOZYerc0130_provenance.
- NP101069.RAwyo1l2NVhzHuA0IX8-ZSInYEbOaFM1XIgP1UOZYerc0130_assertion wasDerivedFrom lhgdn-20090331 NP101069.RAwyo1l2NVhzHuA0IX8-ZSInYEbOaFM1XIgP1UOZYerc0130_provenance.
- NP101069.RAwyo1l2NVhzHuA0IX8-ZSInYEbOaFM1XIgP1UOZYerc0130_assertion wasGeneratedBy ECO_0000203 NP101069.RAwyo1l2NVhzHuA0IX8-ZSInYEbOaFM1XIgP1UOZYerc0130_provenance.